{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:04:59Z","timestamp":1792703099958,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to investigate the regulatory mechanism by which the acidic microenvironment modulates LAMC2 expression in non-small cell lung cancer (NSCLC) and to elucidate its roles in tumor cell proliferation, migration, invasion, and associated signaling pathways, thereby providing a theoretical foundation for targeted lung cancer therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cohort of 104 pathologically confirmed NSCLC patients treated at a designated hospital from January 2018 to December 2021 was enrolled. RNA-seq data from the TCGA database were analyzed to evaluate LAMC2 expression differences and prognostic implications using the GEPIA2 tool.\n                      <jats:italic>In vitro<\/jats:italic>\n                      assays assessed the acidic microenvironment\u2019s impact on LAMC2 expression, with functional evaluations of LAMC2 overexpression and knockdown on cellular behaviors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The LAMC2 mRNA levels were elevated across multiple tumor types and correlated with unfavorable prognoses in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). The acidic microenvironment significantly upregulated LAMC2 expression through HIF-1\u03b1-mediated transcriptional activation. LAMC2, in turn, promoted NSCLC cell proliferation, migration, and invasion by activating the PI3K\/Akt signaling pathway and inducing epithelial\u2013mesenchymal transition (EMT). Clinically, a high LAMC2 expression was associated with poor tumor differentiation, advanced TNM staging, and reduced 3-year survival rates. Moreover, LAMC2 positively correlated with immune checkpoint molecules (e.g., PD-L1, CTLA-4), implying its involvement in immune evasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The acidic microenvironment upregulates LAMC2 via HIF-1\u03b1-mediated transcriptional regulation and lactate accumulation, thereby driving malignant progression in NSCLC. Elevated LAMC2 levels are linked to enhanced proliferation, migration, invasion, and dismal patient outcomes, underscoring its potential as a therapeutic target for precision oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1747868","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:24:55Z","timestamp":1774329895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Acidic microenvironment-induced LAMC2 expression promotes proliferation, migration, and pathway regulation in non-small cell lung cancer cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[{"name":"Research Center for High Altitude Medicine, Key Laboratory of High-Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Lab for High Altitude Medicine), Qinghai University","place":["Xining, China"]},{"name":"Department of Hematology, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengliang","family":"Huang","sequence":"additional","affiliation":[{"name":"Central Laboratory\/Key Laboratory of Echinococcosis Research, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaogang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Central Laboratory\/Key Laboratory of Echinococcosis Research, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hou","sequence":"additional","affiliation":[{"name":"Central Laboratory\/Key Laboratory of Echinococcosis Research, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Central Laboratory\/Key Laboratory of Echinococcosis Research, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Scientific Research Management, Qinghai University Affiliated Hospital","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in non-small-cell lung cancer harboring a KRAS(G12C) mutation","volume":"387","author":"J\u00e4nne","year":"2022","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.10613","article-title":"Ivonescimab plus chemotherapy in non-small cell lung cancer with EGFR variant: a randomized clinical trial","volume":"332","author":"Fang","year":"2024","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the Neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.1038\/s41467-024-54434-4","article-title":"Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment","volume":"15","author":"Song","year":"2024","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071788","article-title":"Therapies targeting immune cells in tumor microenvironment for non-small cell lung cancer","volume":"15","author":"Ye","year":"2023","journal-title":"Pharmaceutics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12916-022-02670-0","article-title":"Tumor PKC\u03b4 instigates immune exclusion in EGFR-mutated non-small cell lung cancer","volume":"20","author":"Zuo","year":"2022","journal-title":"BMC Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12964-020-00653-3","article-title":"Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells","volume":"18","author":"Dong","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647559","article-title":"Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2304161","article-title":"Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9","volume":"25","author":"Yan","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114474","article-title":"Lactate promotes the epithelial-mesenchymal transition of liver cancer cells via TWIST1 lactylation","volume":"447","author":"Huimin","year":"2025","journal-title":"Exp Cell Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309010","article-title":"Oncogenic roles of laminin subunit gamma-2 in intrahepatic cholangiocarcinoma via promoting EGFR translation","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgab011","article-title":"LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma","volume":"42","author":"Okada","year":"2021","journal-title":"Carcinogenesis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00432-024-05720-7","article-title":"LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K\/Akt signaling pathway","volume":"150","author":"Cheng","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1615\/critreveukaryotgeneexpr.2022045308","article-title":"Silencing of LAMC2 reverses epithelial mesenchymal transition and inhibits progression in pancreatic ductal adenocarcinoma via inactivation of the NF-\u03baB signaling pathway","volume":"33","author":"Huang","year":"2023","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147227","article-title":"LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer","volume":"860","author":"He","year":"2023","journal-title":"Gene"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/jca.55627","article-title":"Intrahepatic cholangiocarcinoma cells promote epithelial-mesenchymal transition of hepatocellular carcinoma cells by secreting LAMC2","volume":"12","author":"Cen","year":"2021","journal-title":"J Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-025-02755-9","article-title":"Genomic profiling and personalized treatment strategies for skin Malignancies: findings from the center for cancer genomics and advanced therapeutics database","author":"Hida","year":"2025","journal-title":"Int J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s13402-024-00969-z","article-title":"Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells","volume":"48","author":"Peppicelli","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.06.009","article-title":"miR-7\/TGF-\u03b22 axis sustains acidic tumor microenvironment-induced lung cancer metastasis","volume":"12","author":"Su","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s10020-024-00827-6","article-title":"Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC Malignancy via up-regulating CD44\/STAT3 signaling pathway","volume":"30","author":"Wang","year":"2024","journal-title":"Mol Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41419-024-06898-x","article-title":"PRMT1 promotes Warburg effect by regulating the PKM2\/PKM1 ratio in non-small cell lung cancer","volume":"15","author":"Peng","year":"2024","journal-title":"Cell Death Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.010","article-title":"Lactate induces production of the tRNA(His) half to promote B-lymphoblastic cell proliferation","volume":"28","author":"Mo","year":"2020","journal-title":"Mol Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101197","article-title":"N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma","volume":"79","author":"Xu","year":"2025","journal-title":"Drug Resist Update"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ar.24685","article-title":"Comparative study of the external auditory canal in humans and large mammals","volume":"305","author":"Wang","year":"2022","journal-title":"Anat Rec (Hoboken)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.32604\/or.2023.029064","article-title":"LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K\/AKT\/mTOR pathway in oral","volume":"31","author":"Shan","year":"2023","journal-title":"Oncol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ccs3.12018","article-title":"Lactate drives CD38 signaling to promote epithelial-mesenchymal transition through Snail induction in non-small cell lung cancer cells","volume":"18","author":"Lu","year":"2024","journal-title":"J Cell Commun Signal"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.577530","article-title":"GPR115 contributes to lung adenocarcinoma metastasis associated with LAMC2 and predicts a poor prognosis","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.171","article-title":"Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer","volume":"113","author":"Korbakis","year":"2015","journal-title":"Br J Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00654-7","article-title":"LAMC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer","volume":"30","author":"Tong","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae036","article-title":"Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing hypoxia-inducible factor 1 alpha activity","volume":"26","author":"Huang","year":"2024","journal-title":"Neuro Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63852","article-title":"Hypoxia-inducible factor 1-alpha (HIF-1\u03b1): an essential regulator in cellular metabolic control","volume":"16","author":"Basheeruddin","year":"2024","journal-title":"Cureus"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1747868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:24:55Z","timestamp":1774329895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1747868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1747868"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1747868","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1747868"}}